Navigation Links
Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery

Largest Randomized Safety Program of Intravenous Antihypertensives to Date Presented at ACC Scientific Sessions

NEW ORLEANS, March 27, 2007 /PRNewswire-FirstCall/ -- Findings from ECLIPSE**, the largest safety program comparing intravenous antihypertensive therapies, show that improved control of perioperative hypertension -- a potentially harmful elevation in blood pressure just before, during and/or after surgery - - in patients undergoing cardiac surgery is strongly associated with a reduced risk of death within 30 days following the procedure. The findings were presented at a late-breaking session here at the 56th Annual Scientific Session of the of Cardiology (ACC).

"Perioperative hypertension is a very common problem in cardiac surgery, affecting up to 80 percent of patients," said lead author of the presentation, Solomon Aronson, MD, Duke University Medical Center**. "Findings from ECLIPSE are the first to quantify the relationship between perioperative blood pressure control and clinical outcomes, and demonstrate that better control can dramatically reduce the rate of death in cardiac surgery patients."

"This ECLIPSE analysis contributes to advances in the understanding and treatment of acute hypertension, a condition which affects nearly 3 million people in the U.S. each year," said John Kelley, President and Chief Operating Officer of The Medicines Company. "The Medicines Company is committed to further understanding the importance of better blood pressure control in the acute care setting and we strive to help improve the outcomes of patients who face this life-threatening condition."

Study and Findings

The ECLIPSE program included a total of 1,964 cardiac surgery patients each enrolled in one of three randomized, open-label trials comparing Cleviprex(TM) (clevidipine) to current intravenous antihypertensive agents: nitroglycerin, sodium nitroprusside or nicardipine. Begin
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
2. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
3. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
4. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
5. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
6. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
10. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
11. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
Post Your Comments:
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of the  "North America ... Forecasts (2014 - 2019)"  report to their ... Ultrasound is a type of imaging. ... at body parts and structures inside the ...
(Date:5/28/2015)... May 28, 2015 The Parenteral Drug ... a supporting organization of the Johnson & Johnson ... 2016. Johnson & Johnson (J&J) is ... superbug infections in endoscopes. J&J ran 8 conferences ... 1976 and 2003 on advances in sterilization and ...
(Date:5/28/2015)... Calif. , May 28, 2015  CytomX, a ... cancer, today announced that Sean McCarthy , D. ... Jefferies 2015 Global Healthcare Conference in ... on Tuesday, June 2, 2015. Dr. McCarthy will provide ... Precision cancer immunotherapy and Probody drug conjugate programs. ...
Breaking Medicine Technology:North America Ultrasound Devices Market Report 2014-2019 - Technology and Applications 2PDA Announces Support for the Johnson & Johnson Kilmer Conference 2
... Bioscience has entered into an agreement with ACAP Health ... the trajectory of their healthcare trends through reducing the ... The agreement allows ACAP Health to offer the PreDx® ... of its disease intervention programs. The PreDx DRS is ...
... JERSEY CITY, N.J., Dec. 7, 2011 Aoxing ... Pharma"), a specialty pharmaceutical company focusing on research, ... addiction treatment pharmaceuticals, today announced that its operating ... has signed a three-way financing agreement with Shijiazhuang ...
Cached Medicine Technology:Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 2Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 3Aoxing Pharmaceutical Company Announces $3.2 Million Financing 2Aoxing Pharmaceutical Company Announces $3.2 Million Financing 3
(Date:5/28/2015)... (PRWEB) May 28, 2015 Senior Housing ... legend Lou Piniella, who managed the Seattle Mariners team ... Piniella will appear in television and digital advertising for ... living apartment communities, including several new communities slated to ... Bellevue, Bothell, Lynnwood, Mountlake Terrace, Tukwila, and University Place. ...
(Date:5/28/2015)... 28, 2015 More than 300 locations ... raise money to help the Muscular Dystrophy Association save ... and related life-threatening diseases that limit muscle strength and ... program. , From June 1 to June 30, sweetFrog ... the opportunity to help send local children affected by ...
(Date:5/28/2015)... Jacksonville, Fla. (PRWEB) May 28, 2015 ... center dedicated to patients suffering from acute stroke or ... Emergency Medicine is one of a few in the ... and other neurological emergency needs such as brain aneurysms. ... facilities to take care of patients who are impacted ...
(Date:5/28/2015)... May 28, 2015 ZH Healthcare (ZH), ... that it is releasing BlueEHS, the Electronic Health Solution, ... Image for the benefit of all AWS users worldwide. ... a first of its kind, Freemium, SaaS, Electronic Health ... Records (EHR) with an integrated practice management system (PMS), ...
(Date:5/28/2015)... Edmond, OK (PRWEB) May 28, 2015 ... pain relief lotion and products, today announced their best-selling lotion ... bottle. Real Time Pain Relief is an FDA registered OTC ... natural and herbal ingredients, such as Aloe Vera, Arnica, Capsicum, ... a low level of Menthol – only 1.25% – to ...
Breaking Medicine News(10 mins):Health News:SHAG Announces New Spokesperson: Lou Piniella 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 2Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 3Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2
... 5 NeurogesX, Inc.,(Nasdaq: NGSX ), a ... management therapies, announced today that it is,scheduled to ... Seventh Annual,Needham & Company Biotechnology and Medical Technology ... be presenting at the,conference and will be available ...
... 5 Charterhouse Group, Inc.,("Charterhouse") a New ... and supported growing middle-market companies since 1973,announced ... Partners,("Highlander") and MTS Health Investors ("MTS") to ... Inc. ("CEA" or the "Company"), the,market leader ...
... Leads Combination to Form Nation,s, Foremost Distributor ... SYLMAR, Calif. and DUBLIN, Ohio, June 5 ... and a leading,distributor of emergency medical services (EMS) ... of EMS products, announced today,that they have merged ...
... Detecting CXCR4 HIV-1 Levels as Low as 0.3%, ... Monogram,Biosciences, Inc. (Nasdaq: MGRM ) today announced ... Trofile was introduced,commercially upon FDA approval of Selzentry(TM) ... 2007. Optimization of Monogram,s,Trofile(TM) HIV co-receptor tropism assay ...
... Jeffery Sterman, Public Affairs,Director and voice of Kaiser ... discrimination and breach of contract. A person with AIDS,Sterman ... response to HIV,and AIDS., David J. St. Louis, ... San Francisco and Kaiser Foundation Health Plan was,served June ...
... downplay antibiotic treatment for longstanding symptoms, PORTLAND, Ore., ... into the woods, it also exposes them to tick ... fastest growing infectious diseases in,the United States. A microscopic ... the Lyme infection. Although the,incidence of Lyme disease remains ...
Cached Medicine News:Health News:NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference 2Health News:NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference 3Health News:Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals 2Health News:Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals 3Health News:Tri-anim and Bound Tree Medical Merge to Create Nation's Leading Specialty Health Care Distributor 2Health News:Tri-anim and Bound Tree Medical Merge to Create Nation's Leading Specialty Health Care Distributor 3Health News:Tri-anim and Bound Tree Medical Merge to Create Nation's Leading Specialty Health Care Distributor 4Health News:Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay 2Health News:Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay 3Health News:Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay 4Health News:Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay 5Health News:Kaiser Permanente Sued By Executive for AIDS Discrimination 2Health News:When Are Antibiotics for Lyme Disease Medically Necessary? 2Health News:When Are Antibiotics for Lyme Disease Medically Necessary? 3
2.5 mm cups angled 50 degrees, 10 mm from angle to tip. Serrated handle with polished finish....
Tennant straight tying forceps, 6.0 mm tying platforms, with pin, extra delicate smooth jaws....
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Gills Colibri forceps, very fine pointed tips....
Medicine Products: